HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew L Melton Selected Research

PKI 402

1/2021PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew L Melton Research Topics

Disease

1Neoplasms (Cancer)
01/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021

Drug/Important Bio-Agent (IBA)

1PKI 402IBA
01/2021
12- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA
01/2021
1Radioisotopes (Radionuclides)IBA
01/2021
1Peptide Receptors (Peptide Receptor)IBA
01/2021

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2021
1Radiotherapy
01/2021
1Therapeutics
01/2021